NCT03287726 is a NA clinical trial of probiotics in Obesity, sponsored by Norwegian University of Science and Technology.

Who is sponsoring NCT03287726?

NCT03287726 is sponsored by Norwegian University of Science and Technology.

What drugs are being tested in NCT03287726?

Interventions in NCT03287726: probiotics, placebo.

Is NCT03287726 still recruiting?

NCT03287726 is currently completed. Last updated 4 March 2021.

Last reviewed 2021-03-04 · How we verify

NCT03287726

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

What is the Impact of Probiotics on Weight Loss Maintenance in Individuals With Obesity?

Completed NA Last updated 4 March 2021

What this trial tests

NA trial testing probiotics in Obesity in 76 participants. Completed in 31 December 2020.

Timeline

16 November 2017

Primary endpoint
31 December 2020

31 December 2020

Quick facts

Lead sponsor	Norwegian University of Science and Technology
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	76
Start date	16 November 2017
Primary completion	31 December 2020
Estimated completion	31 December 2020
Sites	1 location across Norway

Drugs / interventions tested

probiotics — full drug profile →
placebo

Conditions studied

Obesity — all drugs for Obesity →

Sponsor

Norwegian University of Science and Technology

Who can join

Adults 18 to 65, any sex, with Obesity. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Weight loss maintenance is the biggest challenge in obesity management, with the majority of weight-reduced individuals experiencing weight regain. The intake of probiotics has been shown to help in weight loss, but its potential in maximizing weight loss maintenance remains unknown. Therefore, the main aim of this study is to investigate the impact of probiotic consumption on weight loss maintenance. Secondary aims are to investigate if the intake of probiotics influences gut microbiota, cardio-metabolic profile, appetite and inflammatory markers.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Metabolic adaptation is an illusion, only present when participants are in negative energy balance.
Martins C, Roekenes J, Salamati S, Gower BA, et al · · 2020 · cited 44× · PMID 32844188 · DOI 10.1093/ajcn/nqaa220

Verify or expand the search:

Other trials of probiotics

Trials testing the same drug.

NCT07333313 — Study of Oral Uremic Toxin Absorbent/Probiotics to Modulate Systemic Inflammation and Retard the Progression of Chronic · NA · recruiting
NCT07182942 — The Effect and Mechanism of Xiqing Regulating Intestinal Homeostasis on Drug Efficacy of Chronic Kidney Disease · Phase 4 · recruiting
NCT06554314 — Effect of Probiotics on Regulating Gut Health and Blood Lipid in Adults · NA · recruiting
NCT06381479 — Exploring the Effects of Probiotics on Workplace Related Stress Symptoms · NA · completed
NCT06118294 — Efficacy of Probiotics for Parkinson Disease (PD) · NA · withdrawn

Other recruiting trials for Obesity

Currently open trials in the same condition.

NCT07403604 — Effect of Insulin Lowering on Lipogenesis · Phase 1 · recruiting
NCT07509307 — AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee · Phase 3 · recruiting
NCT07272837 — Impact of Semaglutide (Ozempic/Wegovy®) on Heart and Muscle Mass · recruiting
NCT07481630 — A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoart · Phase 3 · recruiting
NCT07527195 — Understanding the Effect of CagriSema, Cagrilintide, and Semaglutide on Muscle Health (Role of Amylin Signature in Muscl · Phase 1 · recruiting

Other Norwegian University of Science and Technology trials

Trials by the same sponsor.

NCT07521891 — Socket-leg Interface Movements in Transtibial Amputees · NA · not yet recruiting
NCT07463001 — Optimization and Testing Effectiveness of a Collaborative Intervention for School Attendance Problems in Norwegian Munic · NA · not yet recruiting
NCT07422597 — Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prost · NA · recruiting
NCT06558851 — The Effect of Systematic Endurance Training in Treatment of Women With Lipedema · NA · active not recruiting
NCT06893874 — A Pragmatic Trial of Machine Prescription for Migraine · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03287726 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Norwegian University of Science and Technology
Last refreshed: 4 March 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03287726.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing